# Diurnal Regulation and Gene-Specific Vulnerability of Oxidative Alcohol-Metabolizing Enzymes to Circadian Disruption

**Authors:** Yool Lee, Ali Keshavarzian, Byoung-Joon Song

PMC · DOI: 10.3390/ijms27042041 · International Journal of Molecular Sciences · 2026-02-22

## TL;DR

This study explores how alcohol-metabolizing enzymes in the liver are regulated by the body's internal clock and how disruptions to this clock affect enzyme activity and alcohol-related tissue damage.

## Contribution

The study identifies ALDH2 as uniquely vulnerable to circadian misalignment and reveals gene- and tissue-specific regulation of alcohol-metabolizing enzymes.

## Key findings

- ALDH2 is most disrupted by environmental and metabolic perturbations, including sleep deprivation and high-fat diets.
- CYP2E1 and ALDH2 rhythms persist in Bmal1 knockout and Clock mutant livers under light–dark conditions but are abolished in constant darkness.
- Night-shift workers show dampened and phase-shifted ALDH2 rhythms in peripheral blood mononuclear cells.

## Abstract

Oxidative alcohol metabolism in the liver relies on sequential enzymatic reactions involving alcohol dehydrogenase (ADH), cytochrome P450 2E1 (CYP2E1), and aldehyde dehydrogenase (ALDH) isozymes. However, the circadian regulation of these enzymes, their susceptibility to genetic, environmental, and metabolic disruption, and their functional implications toward alcohol-mediated tissue injury remain incompletely defined. To address this gap, we performed a comprehensive integrative analysis of the publicly available circadian transcriptome datasets spanning genetic clock disruption, acute sleep deprivation, chronic high-fat diet feeding, and occupational shift work to systematically characterize the temporal regulation and disruption vulnerability of the major alcohol-metabolizing enzymes. Mouse tissue-cycling analyses revealed pronounced gene- and tissue-specific diurnal regulation, with Adh1 oscillating primarily in adipose tissues; Cyp2e1 and mitochondrial Aldh2 cycling broadly across kidney, aorta, lung, adrenal gland, and liver; and cytosolic Aldh1b1 being uniformly arrhythmic. In the liver, Cyp2e1 and Aldh2 exhibited robust ~24 h oscillations that peaked during the light/resting phase, while Adh1 showed inconsistent rhythmicity and Aldh1b1 remained arrhythmic. Notably, Cyp2e1 and Aldh2 rhythms persisted in Bmal1 knockout and Clock mutant livers under light–dark conditions, despite complete loss of core clock gene oscillations, yet were abolished in constant darkness, revealing that systemic zeitgeber cues can mask the loss of intrinsic clock function to maintain apparent rhythmicity in these metabolic genes. Systematic cross-paradigm comparison established a novel gene-specific vulnerability hierarchy. Aldh2 was found to be most disrupted by environmental and metabolic perturbations, with acute sleep deprivation eliminating its rhythmicity and temporal expression pattern and a Western-style high-fat diet inducing pronounced phase delays and rhythm loss relative to low-fat diet controls. Both disruptions paralleled alterations in hepatocyte nuclear factor 4α (Hnf4a), newly implicating HNF4α as a potential mediator of ALDH2 circadian instability. In humans, ALDH2 and CYP2E1 exhibited conserved but phase-inverted circadian rhythms across multiple tissues relative to mice, and, importantly, night-shift workers showed markedly dampened and phase-shifted ALDH2 rhythms in peripheral blood mononuclear cells, providing the molecular link between occupational circadian misalignment and impaired acetaldehyde detoxification. Collectively, our detailed and innovative analytical approach reveals gene- and tissue-specific circadian regulation of alcohol-metabolizing enzymes, identifies ALDH2 as uniquely vulnerable to circadian misalignment, underscores the importance of circadian timing for optimal hepatic detoxification and resistance to tissue injury, and suggests that monitoring circadian rhythms could help tailor individualized advice on alcohol consumption for shift workers and populations with irregular sleep schedules, informing precision medicine approaches for alcohol-related disorders.

## Linked entities

- **Genes:** ADH1A (alcohol dehydrogenase 1A (class I), alpha polypeptide) [NCBI Gene 124], CYP2E1 (cytochrome P450 family 2 subfamily E member 1) [NCBI Gene 1571], ALDH2 (aldehyde dehydrogenase 2 family member) [NCBI Gene 217], ALDH1B1 (aldehyde dehydrogenase 1 family member B1) [NCBI Gene 219], BMAL1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 406], CLOCK (clock circadian regulator) [NCBI Gene 9575], HNF4A (hepatocyte nuclear factor 4 alpha) [NCBI Gene 3172]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Rora (RAR-related orphan receptor alpha) [NCBI Gene 19883] {aka 9530021D13Rik, Nr1f1, ROR1, ROR2, ROR3, nmf267}, ALDH2 (aldehyde dehydrogenase 2 family member) [NCBI Gene 217] {aka ALDH-E2, ALDHI, ALDM}, Per3 (period circadian clock 3) [NCBI Gene 18628] {aka 2810049O06Rik, mPer3}, HNF4A (hepatocyte nuclear factor 4 alpha) [NCBI Gene 3172] {aka FRTS4, HNF4, HNF4a7, HNF4a8, HNF4a9, HNF4alpha}, Bmal1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 11865] {aka Arnt3, Arntl, BMAL1b, MOP3, bHLHe5, bmal1b'}, Akr1a1 (aldo-keto reductase family 1, member A1) [NCBI Gene 58810] {aka 2610201A18Rik, Akr1a4}, Cry2 (cryptochrome circadian regulator 2) [NCBI Gene 12953] {aka D130054K12Rik}, ALDH1B1 (aldehyde dehydrogenase 1 family member B1) [NCBI Gene 219] {aka ALDH5, ALDHX}, Adh1 (alcohol dehydrogenase 1 (class I)) [NCBI Gene 11522] {aka ADH-A2, ADH-AA, Adh-1, Adh-1-t, Adh-1e, Adh-1t}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Nr1d1 (nuclear receptor subfamily 1, group D, member 1) [NCBI Gene 217166] {aka A530070C09Rik}, Ppard (peroxisome proliferator activator receptor delta) [NCBI Gene 19015] {aka NUC-1, NUC1, Nr1c2, PPAR-beta, PPAR-delta, PPAR[b]}, Hnf1a (HNF1 homeobox A) [NCBI Gene 21405] {aka HNF1, HNF1-alpha, HNF1[a], Hnf-1, Hnf1alpha, LFB1}, BMAL1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 406] {aka ARNTL, ARNTL1, BMAL1c, JAP3, MOP3, PASD3}, ADH1A (alcohol dehydrogenase 1A (class I), alpha polypeptide) [NCBI Gene 124] {aka ADH1}, Cyp2e1 (cytochrome P450, family 2, subfamily e, polypeptide 1) [NCBI Gene 13106] {aka CYPIIE1, Cyp2e}, Ep300 (E1A binding protein p300) [NCBI Gene 328572] {aka A430090G16, A730011L11, KAT3B, p300, p300 HAT}, Hnf4a (hepatic nuclear factor 4, alpha) [NCBI Gene 15378] {aka HNF-4, Hnf4, Hnf4alpha, MODY1, Nr2a1, TCF-14}, Per1 (period circadian clock 1) [NCBI Gene 18626] {aka Hftm, Per, m-rigui, mPer1}, Cry1 (cryptochrome circadian regulator 1) [NCBI Gene 12952] {aka Phll1}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, AKR1A1 (aldo-keto reductase family 1 member A1) [NCBI Gene 10327] {aka ALDR1, ALR, ARM, DD3, HEL-S-6}, Clock (clock circadian regulator) [NCBI Gene 12753] {aka 5330400M04Rik, KAT13D}, Rorb (RAR-related orphan receptor beta) [NCBI Gene 225998] {aka Nr1f2, RZR-beta, RZRB, Rorbeta, hstp}, Nr1d2 (nuclear receptor subfamily 1, group D, member 2) [NCBI Gene 353187] {aka RVR, Rev-erb}, Aldh1b1 (aldehyde dehydrogenase 1 family, member B1) [NCBI Gene 72535] {aka 2700007F14Rik}, CYP2E1 (cytochrome P450 family 2 subfamily E member 1) [NCBI Gene 1571] {aka CPE1, CYP2E, P450-J, P450C2E}, PER2 (period circadian regulator 2) [NCBI Gene 8864] {aka FASPS, FASPS1}, Per2 (period circadian clock 2) [NCBI Gene 18627] {aka mKIAA0347, mPer2}, Aldh3a1 (aldehyde dehydrogenase family 3, subfamily A1) [NCBI Gene 11670] {aka Ahd-4, Ahd4, Aldh, Aldh3}, Aldh2 (aldehyde dehydrogenase 2, mitochondrial) [NCBI Gene 11669] {aka AHD-M1, ALDH-E2, ALDHI, Ahd-5, Ahd5}, CLOCK (clock circadian regulator) [NCBI Gene 9575] {aka KAT13D, bHLHe8}
- **Diseases:** obesity (MESH:D009765), organ damage (MESH:D000092124), Acute sleep deprivation (MESH:D012892), gut and liver injury (MESH:D017093), acute (MESH:D000208), arrhythmic (OMIM:212500), hepatocellular carcinoma (MESH:D006528), alcohol-related diseases (MESH:D019973), tissue damage (MESH:D017695), damage (MESH:D020263), endotoxemia (MESH:D019446), alcohol flush reaction (MESH:D005483), inflammatory (MESH:D007249), injury to (MESH:D014947), neurodegeneration (MESH:D019636), mitochondrial dysfunction (MESH:D028361), alcohol use disorders (MESH:D000437), death (MESH:D003643), DD (MESH:C536170), Sleep Loss (MESH:D012893), gut and brain injury (MESH:D001930), cancer (MESH:D009369), behavioral impairment (MESH:D001523), addiction (MESH:D019966), insulin resistance (MESH:D007333), circadian disruption (MESH:D019958), toxicity (MESH:D064420), acute liver injury (MESH:D017114)
- **Chemicals:** lipid (MESH:D008055), Cys (MESH:D003545), LPS (MESH:D008070), Acetaldehyde (MESH:D000079), Alcohol (MESH:D000438), NAD+ (MESH:D009243), acetate (MESH:D000085), aldehyde (MESH:D000447), ROS (MESH:D017382), Ethanol (MESH:D000431), melatonin (MESH:D008550), Alda-1 (-), fat (MESH:D005223), acetaminophen (MESH:D000082), O2 (MESH:D010100), NADP+ (MESH:D009249), tamoxifen (MESH:D013629), lipid peroxides (MESH:D008054), sulforaphane (MESH:C016766)
- **Species:** Danio rerio (leopard danio, species) [taxon 7955], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940399/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940399/full.md

## References

109 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940399/full.md

---
Source: https://tomesphere.com/paper/PMC12940399